FINORGA SAS

Overview

FINORGA SAS is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering ADAPALENE; ESMOLOL HYDROCHLORIDE; ICOSAPENT ETHYL.

API / Drug Master Files

FINORGA SAS holds 3 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ICOSAPENT ETHYLActive2013-05-23
• ADAPALENEActive1990-10-12
• ESMOLOL HYDROCHLORIDEActive1987-01-20
• FENOFIBRATEInactive2011-10-28
• TMC 125Inactive2001-10-24
• TIAPRIDE HYDROCHLORIDEInactive1998-12-02
• LEVOBETAXOLOL HYDROCHLORIDEInactive1998-10-19
• N-(2-DEOXY-2-L-LEUCYLAMINO-B-D-GLUCOPYRANOSYL)-N-OCTADECYL-DODECANAMIDEInactive1997-11-13
• 6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYLURACILInactive1997-08-14
• ZOLPIDEM TARTRATE MODIFIED SYNTHESISInactive1995-12-05
• RITONAVIRInactive1995-09-11
• PHENYLOXYCARBONYL-(L)-VALINE METHYL ESTERInactive1995-03-30
• 2-BUTYL-4(5)-CHLORO-1H-IMIDAZOLE-5(4)-CARBOXALDEHYDEInactive1993-08-27
• BETAXOLOL HYDROCHLORIDEInactive1986-03-04

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FINORGA SAS in our records. PharmaTek screens the full directory against live FDA enforcement data.